【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Bone Metastasis Overview 9
Therapeutics Development 10
Pipeline Products for Bone Metastasis – Overview 10
Pipeline Products for Bone Metastasis – Comparative Analysis 11
Bone Metastasis – Therapeutics under Development by Companies 12
Bone Metastasis – Therapeutics under Investigation by Universities/Institutes 14
Bone Metastasis – Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Bone Metastasis – Products under Development by Companies 18
Bone Metastasis – Products under Investigation by Universities/Institutes 20
Bone Metastasis – Companies Involved in Therapeutics Development 21
Ablynx NV 21
Alethia Biotherapeutics Inc. 22
Amgen Inc. 23
Amura Holdings Ltd. 24
Bayer AG 25
ChemoCentryx, Inc. 26
Debiopharm International S.A. 27
Deciphera Pharmaceuticals, LLC 28
Digna Biotech, S.L. 29
Medivir AB 30
Merrion Pharmaceuticals Plc 31
Osteologix Holdings Plc. 32
R-Pharm 33
Sigma-Tau S.p.A. 34
Bone Metastasis – Therapeutics Assessment 35
Assessment by Monotherapy Products 35
Assessment by Combination Products 36
Assessment by Target 37
Assessment by Mechanism of Action 39
Assessment by Route of Administration 41
Assessment by Molecule Type 43
Drug Profiles 45
AB-25E9 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
ADM-01 – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
alendronate sodium + HPMA + paclitaxel – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
alendronate sodium + paclitaxel + PEG – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
ALX-0141 – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
AM-3701 – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
AMG-161 – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
CCX-721 – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
DCC-2909 – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
DCC-3014 – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Debio-0719 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
denosumab – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
disitertide – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
Drugs to Inhibit EGFR for Bone Metastasis – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
MIV-710 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
MIV-711 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
NBS-101 – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
P-17 – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
radium Ra 223 dichloride – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
Recombinant Protein for Bone Metastasis and Non-Small Cell Lung Cancer – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
RPH-203 – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
SST-0001 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
TPH-9 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
Vicrostatin – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
zoledronic acid – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
Bone Metastasis – Recent Pipeline Updates 79
Bone Metastasis – Dormant Projects 95
Bone Metastasis – Discontinued Products 97
Bone Metastasis – Product Development Milestones 98
Featured News & Press Releases 98
May 23, 2014: Daiichi Sankyo Receives Approval in Japan for Additional Indication Related to RANMARK for Treatment of Giant Cell Tumor of Bone 98
Oct 09, 2013: Medivir: Positive results from a phase I study with MIV-711 for the treatment of osteoarthritis and other bone related disorders 98
Oct 01, 2013: Goodwin Biotechnology Announces the Return of AB-25E9 Monoclonal Antibody Project from Alethia Biotherapeutics 99
Jul 17, 2013: The New England Journal of Medicine publishes results from the phase III ALSYMPCA study of Xofigo 100
Jun 20, 2013: Algeta Opens Commercial Production Facility For Xofigo Injection In Kjeller, Norway 101
May 30, 2013: Algeta Announces First Sale Of Xofigo In US 102
Feb 15, 2013: Algeta Presents Further Sub-analysis Of Phase III ALSYMPCA Study Of Radium-223 Dichloride At 2013 Genitourinary Cancers Symposium 103
Jan 14, 2013: US Nuclear Regulatory Commission Issues Licensing Decision For Radium-223 Dichloride 104
Oct 23, 2012: Amgen’s Xgeva Obtains Approval From NICE For Eligibility To NHS Funding 104
Sep 17, 2012: Bayer To Present Data On Alpharadin At ESMO 2012 Congress 105
Appendix 106
Methodology 106
Coverage 106
Secondary Research 106
Primary Research 106
Expert Panel Validation 106
Contact Us 106
Disclaimer 107
【レポート販売概要】
■ タイトル：骨転移(Bone Metastasis)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Bone Metastasis - Pipeline Review, H1 2015
■ 発行日：2015年3月11日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6262IDB
■ 調査対象地域：グローバル
- 世界における神経血管インターベンション市場MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts Summary The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neuro …
- グローバル医療機器市場におけるトップ10企業分析Synopsis The ICD Research Global Top 10 Medical Device Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global medical device industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. Olympus Corporation Johnson & Johnson Dana …
- 世界の政府部門におけるスマートカード市場（2014-2018）About Smart Cards Smart cards are used across various end-user segments for a variety of applications. Smart cards are used extensively for a range of purposes, from basic identification to border security management. Government e-ID cards are cards issued by national governments which give every national a way to prove their identity and residence in their respective country. Various governments …
- 迅速検査サービスの世界市場予測（～2022年）：技術、汚染物質、食品The global market for rapid test has grown exponentially in the last few years. The market size is projected to reach USD 15.71 Billion by 2022, growing at a CAGR of around 7.7% from 2017. Emerging countries such as India, China, India, Brazil, and Argentina are the potential primary markets of the industry. Factors such as rising demand for rapid test result to enhance productivity, increasing fo …
- クラウド型インサイトサービスの世界市場予測（～2021）The Insights-as-a-Service market is expected to grow from USD 1.16 Billion in 2016 to USD 3.33 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 23.5% during the forecast period. The major drivers of this market include better business with new revenue streams, increasing focus on cloud deployment model, and rising need for understanding customer behavior to focus on marketing and sales …
- コンテンツデリバリネットワーク（CDN）の世界市場：主要ベンダー、市場現状、展望Next generation applications, content, and commerce offerings are driving the need for flexible and cost effective Content Delivery Network (CDN) solutions, which core services such as aggregation, management, and distribution of content as well as a variety of value-added functionality. The market need for CDN solutions correlates directly with the explosion of broadband networks, smart mobile ph …
- 医療分野における人工知能（AI）の世界市場予測（～2022年）According to the forecast provided by MarketsandMarkets, the overall artificial intelligence (AI) in healthcare market was valued at USD 667.1 million in 2016 and is expected to reach USD 7,988.8 million by 2022, at a CAGR of 52.68% between 2017 and 2022. The growth of this market is driven by growing usage of Big Data in healthcare industry, ability of AI to improve patient outcomes, imbalance be …
- 電子用接着剤の世界市場：導電性接着剤、熱伝導性接着剤、紫外線硬化型接着剤The global electronic adhesives market size, in terms of value, is projected to reach USD 6,085.4 Million by 2020, at a CAGR of 10.1% between 2015 and 2020. In terms of volume, the global electronic adhesives market is projected to reach 1,916.7 kilotons by 2020, at a CAGR of 5.9% during the forecast period. The increasing number of patents filed for electronic adhesives products & applications by …
- 自動売買システム（システムトレード）の世界市場2016-2020About Automated Trading Systems The automated trading systems are also referred to as algorithmic trading or mechanical trading systems where it allows the trader to establish specific rules for both trade entries and trade exits. They are generally programmed in a way so that they can be automatically executed through computer systems. The entry and exit in the trade is based on the moving averag …
- 貨物輸送管理ソリューションの世界市場Transportation management is a key element in the logistics chain, which joints the separated activities; therefore a good communication between each component of the chain would bring the maximum benefits. The efficient movement of freight is essential to any economy and to the quality of life. Introducing an efficient, cost-effective fright transportation management system supports small and loc …
- 世界の癌診断（検査）市場Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. “New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines …
- 食品ブレンダー及びミキサーの世界市場The blenders & mixers market is directly influenced by the growing processed food industry. The rise in consumption of bakery, beverages, and dairy products in developing economies is driving the market for blenders & mixers. Busy work schedules demand on-the-go consumption and convenient meals. In addition to this, health and wellness consciousness among consumers, and rise in income levels have …
- 半導体製造用ソフトウェアの世界市場2017-2021About Semiconductor Fabrication Software Semiconductor fabrication software comprises design software tools (EDA tools) and production software tools. Electronic design automation (EDA) is a software tool that is used to design electronic systems. It can vary for computer or mobile device chips to chips used in satellites. The value of EDA tools is increasing over time due to the growing complexit …
- 2014年戦略提言：ドイツのフローサイトメトリー市場Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the German flow cytometry market, including:Major issues pertaining to the German flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year …
- ETFE（エチレン-テトラフルオロエチレン共重合体）の世界市場The report covers the global ETFE market and also divides it on the basis of type, technology, applications, and region. The market data for these ETFE types are given with respect to volume (tons) and value ($million). The global market size by value of ETFE was estimated to be $462.14 million in 2014 and is projected to grow at a CAGR of about 9.91% between 2014 and 2019. The data mentioned in t …
